CP
Chetan Purushotam Wadgure
About Chetan Purushotam Wadgure
Data last updated:
Chetan Purushotam Wadgure is a Director at Cure Plus Biosciences Private Limited (since 2020) and Director at Regenerexx Biologics Private Limited (since 2022). The companies operate in Healthcare and Trading. The largest current company by reported revenue is Cure Plus Biosciences Private Limited at ₹2.79 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cure Plus Biosciences Private Limited U51909PN2020PTC191589 | Director | 30 Jun 2020 | 2020 | ₹2.79 Cr (FY 2024) | Active |
 Regenerexx Biologics Private Limited U51909PN2022PTC212789 | Director | 05 Jul 2022 | 2022 | Active |
Board colleagues of Chetan Purushotam Wadgure
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sulbha Laxman Hingane | 10193204 | Cure Plus Biosciences Private Limited | Director |
| Vikram Ashok Rajguru | 09663526 | Regenerexx Biologics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chetan Purushotam Wadgure
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chetan Purushotam Wadgure
Chetan Purushotam Wadgure currently holds 2 directorships: Cure Plus Biosciences Private Limited (Director, since 30 Jun 2020, revenue ₹2.79 Cr (FY 2024)); Regenerexx Biologics Private Limited (Director, since 05 Jul 2022).
Chetan Purushotam Wadgure was first appointed on 30 Jun 2020 as Director at Cure Plus Biosciences Private Limited. The most recent appointment on record is 05 Jul 2022 at Regenerexx Biologics Private Limited.
The current boards of Chetan Purushotam Wadgure's companies include Sulbha Laxman Hingane (Cure Plus Biosciences Private Limited), Vikram Ashok Rajguru (Regenerexx Biologics Private Limited).